Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 23Venous Thromboembolism 1Unilateral Breast Neoplasms 1Triple Negative Breast Neoplasms 1Sarcoma 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms by Site 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Liposarcoma 1Leiomyosarcoma 1HR+HER2- Advanced Breast Cancer 1Glioblastoma 1Endometrial Neoplasms 1EGFR-mutant Non-small Cell Lung Cancer 1Cystadenocarcinoma, Serous 1Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies 1Colorectal Neoplasms 1Cardiovascular Diseases 1Carcinoma, Non-Small-Cell Lung 1Breast Diseases 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Radiotherapy 3Radiation 3palbociclib 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Doxorubicin 2zimberelimab 1talimogene laherparepvec 1sotigalimab 1ribociclib 1pazopanib 1eribulin 1enzalutamide 1durvalumab 1cemiplimab 1abemaciclib 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Nivolumab 1Midazolam 1Letrozole 1Ipilimumab 1Ifosfamide 1Fulvestrant 1Everolimus 1Disulfides 1CTLA-4 Antigen 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Liposarcoma × ribociclib × Clear all
NCT03114527 2026-05-22

Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)

Fox Chase Cancer Center

Phase 2 Active not recruiting
48 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡